UpdatesPlus - Immunology

Description

Source URL:

https://ir.avalotx.com/news-events-presentations/press-releases/detail/220/avalo-therapeutics-achieves-positive-topline-results-in-phase-2-lotus-trial-of-abdakibart-avtx-009-in-moderate-to-severe-hidradenitis-suppurativa